SEPTInvestingStart Free

BBOT 424B3: Board change

Filed with the SEC on · accession 0001193125-26-277572

BBOT filed a 424B3 (prospectus (offering)) with the SEC on Jun 22, 2026. Michelle Doig resigned from the Board of Directors of BridgeBio Oncology Therapeutics upon completion of her term as a Class I director, effective June 16, 2026. The stock moved +4.1% by the first close after the filing.

Summary of the filing

Michelle Doig resigned from the Board of Directors of BridgeBio Oncology Therapeutics upon completion of her term as a Class I director, effective June 16, 2026. The company also held its 2026 Annual Meeting, electing Peter Lebowitz and Frank P. McCormick as Class I directors and ratifying Deloitte & Touche as independent auditor.

For details, click here →How to read a 424B3 →

Key details

Shares of common stock offered by selling securityholders$63.1M
Closing price per share on June 18, 2026$8
FilerBridgeBio Oncology Therapeutics, Inc.
Independent registered public accounting firmDeloitte & Touche LLP
DirectorMichelle Doig
DirectorPeter Lebowitz
DirectorFrank P. McCormick
Chief executive officerPedro J. Beltran

How BBOT stock reacted

Close before

$7.56

Jun 18, 2026

First close after

+4.10%

$7.87

5 trading days

-2.12%

$7.40

Since filing

-71.30%

$2.17

✦ Ask GOAX AI about this filing — what it means for BBOT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BBOT?

Click here

Frequently asked questions

What did BBOT file with the SEC on Jun 22, 2026?

BBOT filed a 424B3 (Board change). Michelle Doig resigned from the Board of Directors of BridgeBio Oncology Therapeutics upon completion of her term as a Class I director, effective June 16, 2026. The company also held its 2026 Annual Meeting, electing Peter Lebowitz and Frank P. McCormick as Class I directors and ratifying Deloitte & Touche as independent auditor.

What does a board change mean for BBOT stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did BBOT stock react to this filing?

BBOT closed at $7.56 before the filing and $7.87 on Jun 22, 2026 (+4.10%). Five trading days later: $7.40 (-2.12%).

Other BBOT SEC filings

Get alerts when BBOT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BBOT overviewBBOT analysisBBOT newsLatest SEC filings